senate · trading 2011-02-01 → 2023-08-08
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2023-08-08 | ROAD | SELL | $250K–$500K | $33.94 | $118.59 2026-08-13 | -249.4% exit |
| 2022-01-31 | ROAD | SELL | $100K–$250K | $26.24 | $118.59 2026-08-13 | -352.0% exit |
| 2021-10-14 | ROAD | SELL | $50K–$100K | $34.75 | $118.59 2026-08-13 | -241.3% exit |
| 2019-02-20 | ZAYO | SELL | $250K–$500K | — | — | — exit |
| 2019-02-19 | ZAYO | SELL | $500K–$1.0M | — | — | — exit |
| 2019-02-19 | CHTR | SELL | $1.0M–$5.0M | $348.43 | $156.53 2026-08-13 | +55.1% exit |
| 2017-11-06 | HALO | SELL | $500K–$1.0M | $17.01 | $100.67 2026-08-13 | -491.8% exit |
| 2017-10-18 | ZIOP | SELL | $250K–$500K | — | — | — exit |
| 2017-10-18 | XON | SELL | $1.0M–$5.0M | — | — | — exit |
| 2016-10-11 | GSK | BUY | $1K–$15K | $42.14 | $50.45 2026-08-13 | +19.7% |
| 2011-02-27 | MSFT | SELL | $15K–$50K | $26.55 | $496.88 2026-08-13 | -1771.5% exit |
| 2011-02-01 | IBM | BUY | $1K–$15K | $156.37 | $237.14 2026-08-13 | +51.7% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Alan S. Lowenthal | 4 · IBM, MSFT, CHTR, ZAYO |
| K. Michael Conaway | 4 · GSK, IBM, MSFT, CHTR |
| Kurt Schrader | 4 · GSK, IBM, MSFT, CHTR |
| Rohit Khanna | 4 · GSK, IBM, MSFT, CHTR |
| George Holding | 4 · GSK, IBM, MSFT, CHTR |
| Josh Gottheimer | 3 · IBM, MSFT, HALO |
| Thomas H Tuberville | 3 · GSK, IBM, MSFT |
| Thomas R Carper | 3 · GSK, IBM, MSFT |
| John Boozman | 3 · GSK, IBM, MSFT |
| Alan Armstrong | 3 · IBM, MSFT, CHTR |
| David P. Roe | 3 · GSK, IBM, MSFT |
| DIANNE FEINSTEIN | 3 · IBM, MSFT, CHTR |